Dr. Hava Gil-Henn – L-Norvaline, a new therapeutic agent against Alzheimer’s disease

AbstractGrowing evidence highlights the role of arginase activity in the manifestation of Alzheimer’s disease (AD). Upregulation of arginase was shown to contribute to neurodegeneration. Regulation of arginase activity appears to be a promising approach for interfering with the pathogenesis of AD. Therefore, the enzyme represents a novel therapeutic target. In this study, we administered an…

Read More